Prediction of Genitourinary Tract Morbidity after Brachytherapy for Prostate Adenocarcinoma

Mayo Clinic Proceedings

Volumn 79, Issue 3, 2004, Pages 314-317

  Wehle, Michael J ^a   Lisson, Scott W ^a   Buskirk, Steven J ^a   Broderick, Gregory A ^a   Young, Paul R ^a   Igel, Todd C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PALLADIUM 103;

ADULT; AGED; BRACHYTHERAPY; CANCER LOCALIZATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; HORMONE INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MORBIDITY; PREOPERATIVE EVALUATION; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SYMPTOM; TRANSURETHRAL RESECTION; URETHROTOMY; URINE FLOW RATE; UROGENITAL TRACT DISEASE;

EID: 1442306871     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.3.314     Document Type: Article

References (16)

1. Pollack A, Zagars GK. External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? Urology. 1998;51:258-264.
2. Kupelian P, Katcher J, Levin H, et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am. 1997;3:78-87.
3. Eastham JA, Kattan MW, Groshen S, et al. Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. J Clin Oncol. 1997;15:3214-3222.
4. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41:491-500.
5. Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 1998;83:989-1001.
6. Middleton RG, Thompson IM, Austenfeld MS, et al. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. J Urol. 1995;154:2144-2148.
7. Arterbery VE, Wallner K, Roy J, Fuks Z. Short-term morbidity from CT-planned transperineal 1-125 prostate implants. Int J Radiat Oncol Biol Phys. 1993;25:661-667.
8. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 1998;160:1379-1382.
9. Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 1999;45: 59-67.
10. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Measurement Committee of the American Urological Association. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. J Urol. 1992;148:1558-1563.
11. Thomas MD, Cormack R, Tempany CM, et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;47:905-908.
12. Peschel RE, Chen Z, Roberts K, Nath R. Long-term complications with prostate implants: iodine-125 vs. palladium-103. Radiat Oncol Investig. 1999;7:278-288.
13. Krumholtz JS, Michalski JM, Sundaram CP. Health-related quality of life and morbidity in patients receiving brachytherapy for clinically localized prostate cancer. J Endourol. 2000;14:371-374.
14. Hu K, Wallner K. Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40:783-786.
15. Girman CJ, Jacobsen SJ, Guess HA, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol. 1995;153:1510-1515.
16. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993;150(2, pt 1):351-358.